Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes
Abstract
Type 2 diabetes (T2D), one of the most common diseases in the western world, is characterized by
* Corresponding authors
a Discovery Research, GlaxoSmithKline, Ware, UK
b Discovery Research, GlaxoSmithKline, 709 Swedeland Rd., King of Prussia, USA
c Ingenuity Systems Inc., 1700 Seaport Blvd., Third Floor, Redwood City, USA
d Safety Assessment, GlaxoSmithKline, 709 Swedeland Rd., King of Prussia, USA
Type 2 diabetes (T2D), one of the most common diseases in the western world, is characterized by
S. C. Connor, M. K. Hansen, A. Corner, R. F. Smith and T. E. Ryan, Mol. BioSyst., 2010, 6, 909 DOI: 10.1039/B914182K
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content